The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 13 of the 39 sources its claims cite were checked for support.
Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet
Open accessAbstract
OBJECTIVE: To test the effects of two Mediterranean diet (MedDiet) interventions versus a low-fat diet on incidence of diabetes. RESEARCH DESIGN AND METHODS: This was a three-arm randomized trial in 418 nondiabetic subjects aged 55-80 years recruited in one center (PREDIMED-Reus, northeastern Spain) of the Prevención con Dieta Mediterránea [PREDIMED] study, a large nutrition intervention trial for primary cardiovascular prevention in individuals at high cardiovascular risk. Participants were randomly assigned to education on a low-fat diet (control group) or to one of two MedDiets, supplemented with either free virgin olive oil (1 liter/week) or nuts (30 g/day). Diets were ad libitum, and no advice on physical activity was given. The main outcome was diabetes incidence diagnosed by the 2009 American Diabetes Association criteria. RESULTS: After a median follow-up of 4.0 years, diabetes incidence was 10.1% (95% CI 5.1-15.1), 11.0% (5.9-16.1), and 17.9% (11.4-24.4) in the MedDiet with olive oil group, the MedDiet with nuts group, and the control group, respectively. Multivariable adjusted hazard ratios of diabetes were 0.49 (0.25-0.97) and 0.48 (0.24-0.96) in the MedDiet supplemented with olive oil and nuts groups, respectively, compared with the control group. When the two MedDiet groups were pooled and compared with the control group, diabetes incidence was reduced by 52% (27-86). In all study arms, increased adherence to the MedDiet was inversely associated with diabetes incidence. Diabetes risk reduction occurred in the absence of significant changes in body weight or physical activity. CONCLUSIONS: MedDiets without calorie restriction seem to be effective in the prevention of diabetes in subjects at high cardiovascular risk.
Overview
CoChat Summary
TL;DR
In a PREDIMED-Reus nested substudy, non–calorie-restricted Mediterranean diets enriched with virgin olive oil or mixed nuts reduced incident diabetes versus a low-fat control diet over a median 4.0 years. Adjusted diabetes incidence fell by 51% and 52%, respectively, without significant weight or physical activity changes.
Key findings
- Among 418 nondiabetic participants, 54 developed new-onset diabetes. Diabetes incidence per 1,000 person-years was 24.6 (95% CI 13.5–40.8) for MedDiet + virgin olive oil, 26.8 (15.3–43.0) for MedDiet + nuts, and 46.6 (30.1–68.5) for control.
- After adjustment, incident diabetes was reduced by 51% in the MedDiet + olive oil group and 52% in the MedDiet + nuts group versus control; merging the two MedDiet groups gave a 52% reduction.
- Weight changes at end of follow-up were −0.2 ± 4.6 kg for olive oil, −0.6 ± 4.2 kg for nuts, and −0.6 ± 4.3 kg for low-fat control (P = 0.74); physical activity changes were similar (P = 0.50).
- In the MedDiet groups, 6.3% of participants who attained ≥4 of 7 prespecified goals developed diabetes versus 15.0% of those attaining <4 goals (P = 0.02).
Methods
- Multicenter, randomized, parallel-group PREDIMED primary prevention trial; this report is a nested substudy at PREDIMED-Reus using yearly oral glucose tolerance tests (OGTTs) in nondiabetic participants. Recruitment ran October 2003–June 2008; 7,232 participants were randomized in PREDIMED overall, and 418 nondiabetic volunteers entered this analysis.
- Participants were community-dwelling men aged 55–80 years and women aged 60–80 years without prior cardiovascular disease but with at least three cardiovascular risk factors; prevalent diabetes, severe chronic illness, alcohol or drug abuse, BMI ≥40 kg/m², and allergy/intolerance to olive oil or nuts were exclusions.
- Interventions were MedDiet + virgin olive oil (1 L/week), MedDiet + mixed nuts (30 g/day), or low-fat control, with no energy restriction or physical activity promotion. Primary outcome was new-onset diabetes by ADA criteria (fasting plasma glucose ≥7.0 mmol/L or 2-h plasma glucose ≥11.1 mmol/L after 75-g glucose load), confirmed by a second test; Cox regression was adjusted for age/sex and additional confounders, with intention-to-treat analysis.
Limitations
- Stated: the cohort was older and at high cardiovascular risk, so generalization to younger/healthier individuals or other geographical locations is uncertain; the lifestyle score may not reflect all dietary changes; some participants did not undergo OGTT (refused 17% of scheduled occasions; 41 [9.8%] had none), possibly lowering incident rates; and the sample was relatively small, based on fewer than 55 incident cases with wide CIs.
- Evident: staff collecting questionnaires and physical measures were unblinded to intervention group.
- Evident: baseline imbalance existed (control group used fewer lipid-lowering drugs and had a lower MedDiet score), and only 21% of control participants achieved total fat intake <35% of energy, indicating limited adherence to the control diet.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
10 Valid · 2 Not valid · 8 Not checked · 44 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Because chronic low-grade inflammation is a pathogenetic factor in diabetes, synergy among the anti-inflammatory properties of the MedDiet and those specific to virgin olive oil ( 18 ) and nuts ( 19 ) might also be relevant to diabetes risk reduction.”
What the sources say
- Not checked — no full text of the sourcecites [18] Covas, 2009, Olive oil and cardiovascular health, J Cardiovasc Pharmacol source
- Supportedcites [19] Ros, 2009, Nuts and novel biomarkers of cardiovascular disease, Am J Clin Nutr source
Citation (19) supports the nut-specific part of the sentence. In “Possible mechanisms for the effects of nuts on novel cardiovascular biomarkers,” Ros describes anti-inflammatory components of nuts and suggests they might be relevant to the lower incidence of diabetes associated with nut consumption. The proposed synergy with the Mediterranean diet and virgin olive oil is the citing authors’ hypothesis, not a finding attributed solely to this source. (LLM, conf=0.90)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our results are consistent with prior evidence suggesting a protective effect of the MedDiet against diabetes ( 7 , 9 – 11 ).”
What the sources say
- Not checked — no full text of the sourcecites [7] Kastorini, 2009, Dietary patterns and prevention of type 2 diabetes; from research to clinical practice; a systematic review, Curr Diabetes Rev source
- Supportedcites [9] Martínez-González, 2008, Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study, BMJ sourceExperimental — accuracy not yet measured
The Additional information summary (p. 6) reports that greater Mediterranean-diet adherence was associated with lower type 2 diabetes incidence among initially healthy participants. The Discussion interprets this finding as suggesting potential for prevention, which supports the citing sentence’s cautious wording. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [10] Mozaffarian, 2007, Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors, Lancet source
- Not checked — no full text of the sourcecites [11] Esposito, 2009, Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial, Ann Intern Med source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Two prospective studies from Southern Europe suggested a lower incidence of diabetes with increasing adherence to the MedDiet in previously healthy individuals ( 9 ) or myocardial infarction survivors ( 10 ).”
What the sources say
- Supportedcites [9] Martínez-González, 2008, Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study, BMJ source
The Abstract describes a prospective cohort of 13,380 initially healthy Spanish participants and reports lower diabetes incidence with greater adherence to a Mediterranean diet. In the citing sentence, this source supports the previously healthy individuals clause; the myocardial infarction survivors clause has a separate citation. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [10] Mozaffarian, 2007, Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors, Lancet source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The results of these studies provide convincing evidence that lifestyle modification reduces the incidence of diabetes among high-risk individuals.”
What the sources say
- Not checked — no full text of the sourcecites [2] Pan, 1997, Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study, Diabetes Care source
- Supportedcites [3] Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med source
The Discussion states that lifestyle changes prevented type 2 diabetes in women and men at high risk, reducing its incidence by 58 percent. The Abstract identifies the participants as overweight people with impaired glucose tolerance. Page numbers are not supplied for these passages. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [4] Kosaka, 2005, Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males, Diabetes Res Clin Pract source
- Not checked — no full text of the sourcecites [5] Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med source
- Supportedcites [6] Ramachandran, 2006, The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1), Diabetologia source
The Discussion reports that lifestyle modification helped prevent diabetes in Asian Indian subjects with impaired glucose tolerance, a high-risk group. It gives a cumulative diabetes incidence of 39.3% in the lifestyle-modification group versus 55% in controls. (LLM, conf=0.93)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“As suggested by the known associations among subtypes of dietary fat and diabetes risk ( 17 ), the increased unsaturated fat load of our MedDiets was probably instrumental in achieving diabetes risk reduction.”
What the sources say
- Supportedcites [17] Riserus, 2009, Dietary fats and prevention of type 2 diabetes, Progr Lipid Res source
The citation supports the sentence’s premise: Section 2.4 reports an inverse association between polyunsaturated fat intake and type 2 diabetes risk. The claim that the authors’ MedDiets achieved risk reduction through their unsaturated fat content is their own inference, not a finding attributed directly to this source. (LLM, conf=0.90)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
20 more claims · 2 with their cited sources checked
Create a free account to see all 64 claims and every source verdict.
- It may state two separate claims as one. 28
- Probably not a substantial claim. 23
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Moreover, the abundant intake of MUFAs or PUFAs with olive oil and seeds, in place of saturated or trans fatty acids, may also reduce the risk of T2D in at-risk patients by up to 83% over a median of 4.4 years [44], even in the absence of caloric-restriction [45].”
From Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases (2020) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In this context, treatment of ABCD employing weight-loss therapy is highly effective for treating persons with prediabetes, metabolic syndrome, T2D, and CVD risk factors who also have overweight or obesity.809”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [809]
Experimental — accuracy not yet measuredIn the citing paper
“The incidence of type 2 diabetes, peripheral artery disease, atrial fibrillation, breast cancer, but not the incidence of heart failure, was significantly reduced in individuals randomized to the Mediterranean diet (25–27).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [25]
In the citing paper
“The MD is a pronounced, but not exclusively vegetarian-oriented dietary style, which has been demonstrated to be beneficial for the treatment of obesity, type 2 diabetes, inflammatory diseases and cardiovascular diseases.[26][27][28][29][30]”
From High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome (2016) · cites this paper as [26]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 3×
“In four of these studies (2-5), diabetes rates decreased in relation to substantial reductions of body weight, while in the Indian trial (6) lifestyle intervention was successful in spite of no weight loss.”
BackgroundResultDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Lindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795 · cited 1×
“prevent diabetes and weight loss is the main predictor of success (1).”
BackgroundAdherence to Mediterranean diet and health status: meta-analysis
Sofi, F., Cesari, F., Abbate, R., Gensini, G. F., & Casini, A. (2008) · BMJ · doi:10.1136/bmj.a1344 · Cited by 1,717 · cited 1×
“Because other studies have shown that the benefit of lifestyle modification in reducing diabetes risk extends beyond the termination of active intervention (23–25), education of the population on the MedDiet might be a safe public health approach to delay or prevent development of diabetes as well as that of other pre…”
BackgroundEffects of a Mediterranean-Style Diet on Cardiovascular Risk Factors: A Randomized Trial
Estruch, R., Martínez-González, M. Á., Corella, D., Salas-Salvadó, J., Ruiz-Gutiérrez, V., Covas, M. I., Fiol, M., Gómez-Gracia, E., López-Sabater, M. C., Vinyoles, E., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00004 · Cited by 1,704
Self-citation
Cited by
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“An RCT looking at high-risk individuals in Spain showed that the Mediterranean dietary pattern reduced the incidence of diabetes in the absence of weight loss by 52% compared with the low-fat control group (132).”
BackgroundRETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
Self-citationRetractedStandards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Metadata
- Authors
- Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M. I., Corella, D., Arós, F., Ruiz-Gutiérrez, V., Ros, E., & for the PREDIMED Study Investigators
- Affiliations
- Human Nutrition Unit, Hospital Universitari de Sant Joan, Departament de Bioquímica i Biotecnologia, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain;
- CIBER Fisiopatologia de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid, Spain;
- Instituto de Salud Carlos III (ES)
- Universitat de València (ES)
- Instituto de la Grasa, Consejo Superior de Investigaciones Científicas, Seville, Spain;
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-07
- Volume
- 34
- Issue
- 1
- Pages
- 14-19
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3005482
- OpenAlex
- W2107073645
- Semantic Scholar
- 8f5c51d8339c9939f39f708edec9ebc346d62276
- Cited by
- 901
- References
- 30
- Citations by year
- 2026: 29 · 2025: 54 · 2024: 49 · 2023: 48 · 2022: 60 · 2021: 66 · 2020: 64 · 2019: 67 · 2018: 75 · 2017: 79 · 2016: 60 · 2015: 54 · 2014: 77 · 2013: 45 · 2012: 41
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Update notices
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- Mediterranean diet, type 2 diabetes prevention, diabetes incidence, virgin olive oil, nuts, low-fat diet, dietary adherence, cardiovascular risk, older adults, PREDIMED study
- MeSH terms
- Olive Oil, Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Nuts, Plant Oils, Risk Factors, Dietary Supplements, Diet, Mediterranean
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet. https://app.cochat.ai/papers/10.2337/dc10-1288
- The paper
- Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M. I., Corella, D., Arós, F., Ruiz-Gutiérrez, V., Ros, E., & for the PREDIMED Study Investigators. (2011). Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet. Diabetes Care. https://doi.org/10.2337/dc10-1288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.